A placebo-controlled study of memantine for the treatment of human immunodeficiency virus-associated sensory neuropathy

Giovanni Schifitto, Constantin Yiannoutsos, David M. Simpson, Christina M. Marra, Elyse J. Singer, Dennis L. Kolson, Avindra Nath, Joseph R. Berger, Bradford Navia

Research output: Contribution to journalArticle

46 Citations (Scopus)

Abstract

Distal sensory polyneuropathy (DSP) is the most frequent neurological complication of HIV infection. Neuropathic symptoms vary from mild paresthesias to severe pain that respond only partially to symptomatic treatment. Forty-five subjects with human immunodeficiency virus (HIV)-associated symptomatic DSP (SDSP) were enrolled in a randomized, multicenter, 16-week placebo-controlled study of memantine, an N-methyl-D-aspartate (NMDA) uncompetitive antagonist. Although memantine was well tolerated, no trend toward clinical benefit was observed. Results were similar to those of other pilot studies of memantine for neuropathic pain unrelated to HIV, suggesting that memantine is ineffective for the symptomatic treatment of HIV-associated SDSP.

Original languageEnglish (US)
Pages (from-to)328-331
Number of pages4
JournalJournal of NeuroVirology
Volume12
Issue number4
DOIs
StatePublished - Aug 2006
Externally publishedYes

Fingerprint

Memantine
Placebos
HIV
Polyneuropathies
Paresthesia
Neuralgia
Virus Diseases
N-Methylaspartate
Therapeutics
Pain

Keywords

  • AIDS
  • HIV
  • Memantine
  • Neuropathy

ASJC Scopus subject areas

  • Virology
  • Clinical Neurology

Cite this

A placebo-controlled study of memantine for the treatment of human immunodeficiency virus-associated sensory neuropathy. / Schifitto, Giovanni; Yiannoutsos, Constantin; Simpson, David M.; Marra, Christina M.; Singer, Elyse J.; Kolson, Dennis L.; Nath, Avindra; Berger, Joseph R.; Navia, Bradford.

In: Journal of NeuroVirology, Vol. 12, No. 4, 08.2006, p. 328-331.

Research output: Contribution to journalArticle

Schifitto, G, Yiannoutsos, C, Simpson, DM, Marra, CM, Singer, EJ, Kolson, DL, Nath, A, Berger, JR & Navia, B 2006, 'A placebo-controlled study of memantine for the treatment of human immunodeficiency virus-associated sensory neuropathy', Journal of NeuroVirology, vol. 12, no. 4, pp. 328-331. https://doi.org/10.1080/13550280600873835
Schifitto, Giovanni ; Yiannoutsos, Constantin ; Simpson, David M. ; Marra, Christina M. ; Singer, Elyse J. ; Kolson, Dennis L. ; Nath, Avindra ; Berger, Joseph R. ; Navia, Bradford. / A placebo-controlled study of memantine for the treatment of human immunodeficiency virus-associated sensory neuropathy. In: Journal of NeuroVirology. 2006 ; Vol. 12, No. 4. pp. 328-331.
@article{8a46adc886fa487cb076f2af7ad2e2bf,
title = "A placebo-controlled study of memantine for the treatment of human immunodeficiency virus-associated sensory neuropathy",
abstract = "Distal sensory polyneuropathy (DSP) is the most frequent neurological complication of HIV infection. Neuropathic symptoms vary from mild paresthesias to severe pain that respond only partially to symptomatic treatment. Forty-five subjects with human immunodeficiency virus (HIV)-associated symptomatic DSP (SDSP) were enrolled in a randomized, multicenter, 16-week placebo-controlled study of memantine, an N-methyl-D-aspartate (NMDA) uncompetitive antagonist. Although memantine was well tolerated, no trend toward clinical benefit was observed. Results were similar to those of other pilot studies of memantine for neuropathic pain unrelated to HIV, suggesting that memantine is ineffective for the symptomatic treatment of HIV-associated SDSP.",
keywords = "AIDS, HIV, Memantine, Neuropathy",
author = "Giovanni Schifitto and Constantin Yiannoutsos and Simpson, {David M.} and Marra, {Christina M.} and Singer, {Elyse J.} and Kolson, {Dennis L.} and Avindra Nath and Berger, {Joseph R.} and Bradford Navia",
year = "2006",
month = "8",
doi = "10.1080/13550280600873835",
language = "English (US)",
volume = "12",
pages = "328--331",
journal = "Journal of NeuroVirology",
issn = "1355-0284",
publisher = "Springer New York",
number = "4",

}

TY - JOUR

T1 - A placebo-controlled study of memantine for the treatment of human immunodeficiency virus-associated sensory neuropathy

AU - Schifitto, Giovanni

AU - Yiannoutsos, Constantin

AU - Simpson, David M.

AU - Marra, Christina M.

AU - Singer, Elyse J.

AU - Kolson, Dennis L.

AU - Nath, Avindra

AU - Berger, Joseph R.

AU - Navia, Bradford

PY - 2006/8

Y1 - 2006/8

N2 - Distal sensory polyneuropathy (DSP) is the most frequent neurological complication of HIV infection. Neuropathic symptoms vary from mild paresthesias to severe pain that respond only partially to symptomatic treatment. Forty-five subjects with human immunodeficiency virus (HIV)-associated symptomatic DSP (SDSP) were enrolled in a randomized, multicenter, 16-week placebo-controlled study of memantine, an N-methyl-D-aspartate (NMDA) uncompetitive antagonist. Although memantine was well tolerated, no trend toward clinical benefit was observed. Results were similar to those of other pilot studies of memantine for neuropathic pain unrelated to HIV, suggesting that memantine is ineffective for the symptomatic treatment of HIV-associated SDSP.

AB - Distal sensory polyneuropathy (DSP) is the most frequent neurological complication of HIV infection. Neuropathic symptoms vary from mild paresthesias to severe pain that respond only partially to symptomatic treatment. Forty-five subjects with human immunodeficiency virus (HIV)-associated symptomatic DSP (SDSP) were enrolled in a randomized, multicenter, 16-week placebo-controlled study of memantine, an N-methyl-D-aspartate (NMDA) uncompetitive antagonist. Although memantine was well tolerated, no trend toward clinical benefit was observed. Results were similar to those of other pilot studies of memantine for neuropathic pain unrelated to HIV, suggesting that memantine is ineffective for the symptomatic treatment of HIV-associated SDSP.

KW - AIDS

KW - HIV

KW - Memantine

KW - Neuropathy

UR - http://www.scopus.com/inward/record.url?scp=33748668056&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33748668056&partnerID=8YFLogxK

U2 - 10.1080/13550280600873835

DO - 10.1080/13550280600873835

M3 - Article

C2 - 16966223

AN - SCOPUS:33748668056

VL - 12

SP - 328

EP - 331

JO - Journal of NeuroVirology

JF - Journal of NeuroVirology

SN - 1355-0284

IS - 4

ER -